0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global and India Hirudin Market Report & Forecast 2023-2029
Published Date: November 2023
|
Report Code: QYRE-Auto-24W15584
Home | Market Reports | Health| Health Conditions
Global and India Hirudin Market Report Forecast 2023 2029
BUY CHAPTERS

Global and India Hirudin Market Report & Forecast 2023-2029

Code: QYRE-Auto-24W15584
Report
November 2023
Pages:99
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

and India Hirudin Market Size

The global Hirudin revenue was US$ 3975 million in 2022 and is forecast to a readjusted size of US$ 4934.7 million by 2029 with a CAGR of 3.1% during the forecast period (2023-2029).

and India Hirudin Market

and India Hirudin Market

This report studies the Hirudin market. Hirudin is a naturally occurring peptide in the salivary glands of medicinal leeches (such as Hirudo medicinalis) that has a blood anticoagulant property. Hirudin is the most potent natural inhibitor of thrombin. Hirudin (hirudin) is a Leech (Leech) and salivary glands have been extracted from a variety of active ingredients in the activity of the most significant and most studied ingredients, which is 65-66 amino acids from the small molecules of protein (peptide) . Hirudin have strong inhibitory effect on thrombin is the strongest so far found in the natural specific inhibitor of thrombin. Animal experiments and clinical studies have shown that hirudin can be effective anticoagulant, antithrombotic, and prevent thrombin-catalyzed activation of coagulation factors and platelet reactions and blood stasis phenomenon further. In addition, it also inhibited thrombin-induced fibroblast proliferation, and thrombin stimulation of endothelial cells. Compared with heparin, which not only use less, do not cause bleeding, is not dependent on endogenous cofactor; and heparin have caused the risk of bleeding, disseminated intravascular coagulation in the pathogenesis of antithrombin III are reduced This will limit the efficacy of heparin, using leeches will have good results.
In India, the Hirudin revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period (2023-2029).
Global Hirudin key players include Pfizer, Teva Pharmaceutical, The Medicines Company, SALUBRIS, DUOPUTAI, etc. Global top five manufacturers hold a share about 20%. North America is the largest market, with a share about 30%, followed by Europe, with a share about 20 percent. In terms of product, Natural Hirudin is the largest segment, with a share about 55%. And in terms of application, the largest application is Thrombosis Disease, followed by Tumor Disease, etc.
This report focuses on global and India Hirudin market, also covers the segmentation data of other regions in regional level and county level.
India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.
India is a market full of opportunities, and the demand for Hirudin will continue to grow rapidly in the future.
Global Hirudin Scope and Market Size
Hirudin market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Hirudin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2029.
For India market, this report focuses on the Hirudin market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in India.

Scope of and India Hirudin Market Report

Report Metric Details
Report Name and India Hirudin Market
Forecasted market size in 2029 US$ 4934.7 million
CAGR 3.1%
Forecasted years 2023 - 2029
Segment by Type
  • Natural Hirudin
  • Recombinant Hirudin
Segment by Application
  • Thrombosis Disease
  • Tumor Disease
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company The Medicines Company, Keyken, Minapharm, Abbott, SALUBRIS, Pfizer, Inc, Teva Pharmaceutical Industries Ltd, DUOPUTAI, Pentapharm
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

What is the and India Hirudin Market size in 2029?

Ans: The and India Hirudin Market size in 2029 will be US$ 4934.7 million.

What is the market share of major companies in and India Hirudin Market?

Ans: Global top five manufacturers hold a share about 20%.

What is the and India Hirudin Market share by type?

Ans: In terms of product, Natural Hirudin is the largest segment, with a share about 55%.

What is the and India Hirudin Market share by region?

Ans: According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment.

Who are the main players in the and India Hirudin Market report?

Ans: The main players in the and India Hirudin Market are The Medicines Company, Keyken, Minapharm, Abbott, SALUBRIS, Pfizer, Inc, Teva Pharmaceutical Industries Ltd, DUOPUTAI, Pentapharm

What are the Application segmentation covered in the and India Hirudin Market report?

Ans: The Applications covered in the and India Hirudin Market report are Thrombosis Disease, Tumor Disease, Others

What are the Type segmentation covered in the and India Hirudin Market report?

Ans: The Types covered in the and India Hirudin Market report are Natural Hirudin, Recombinant Hirudin

1 Study Coverage
1.1 Hirudin Product Introduction
1.2 Global Hirudin Outlook 2018 VS 2022 VS 2029
1.2.1 Global Hirudin Sales in US$ Million for the Year 2018-2029
1.2.2 Global Hirudin Sales in Volume for the Year 2018-2029
1.3 India Hirudin Outlook 2018 VS 2022 VS 2029
1.3.1 India Hirudin Sales in US$ Million for the Year 2018-2029
1.3.2 India Hirudin Sales in Volume for the Year 2018-2029
1.4 Hirudin Market Size, India VS Global, 2018 VS 2022 VS 2029
1.4.1 The Market Share of India Hirudin in Global, 2018 VS 2022 VS 2029
1.4.2 The Growth Rate of Hirudin Market Size, India VS Global, 2018 VS 2022 VS 2029
1.5 Hirudin Market Dynamics
1.5.1 Hirudin Industry Trends
1.5.2 Hirudin Market Drivers
1.5.3 Hirudin Market Challenges
1.5.4 Hirudin Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Years Considered
2 Hirudin by Type
2.1 Hirudin Market Segment by Type
2.1.1 Natural Hirudin
2.1.2 Recombinant Hirudin
2.2 Global Hirudin Market Size by Type
2.2.1 Global Hirudin Sales in Value, by Type (2018, 2022 & 2029)
2.2.2 Global Hirudin Sales in Volume, by Type (2018, 2022 & 2029)
2.2.3 Global Hirudin Average Selling Price (ASP) by Type (2018, 2022 & 2029)
2.3 India Hirudin Market Size by Type
2.3.1 India Hirudin Sales in Value, by Type (2018, 2022 & 2029)
2.3.2 India Hirudin Sales in Volume, by Type (2018, 2022 & 2029)
2.3.3 India Hirudin Average Selling Price (ASP) by Type (2018, 2022 & 2029)
3 Hirudin by Application
3.1 Hirudin Market Segment by Application
3.1.1 Thrombosis Disease
3.1.2 Tumor Disease
3.1.3 Others
3.2 Global Hirudin Market Size by Application
3.2.1 Global Hirudin Sales in Value, by Application (2018, 2022 & 2029)
3.2.2 Global Hirudin Sales in Volume, by Application (2018, 2022 & 2029)
3.3.3 Global Hirudin Average Selling Price (ASP) by Application (2018, 2022 & 2029)
3.3 India Hirudin Market Size by Application
3.3.1 India Hirudin Sales in Value, by Application (2018, 2022 & 2029)
3.3.2 India Hirudin Sales in Volume, by Application (2018, 2022 & 2029)
3.3.3 India Hirudin Average Selling Price (ASP) by Application (2018, 2022 & 2029)
4 Global Hirudin Competitor Landscape by Company
4.1 Global Hirudin Market Size by Company
4.1.1 Global Key Manufacturers of Hirudin, Ranked by Revenue (2022)
4.1.2 Global Hirudin Revenue by Manufacturer (2018-2023)
4.1.3 Global Hirudin Sales by Manufacturer (2018-2023)
4.1.4 Global Hirudin Price by Manufacturer (2018-2023)
4.2 Global Hirudin Concentration Ratio (CR)
4.2.1 Hirudin Market Concentration Ratio (CR)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Hirudin in 2022
4.2.3 Global Hirudin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of Hirudin, Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of Hirudin, Product Offered and Application
4.5 Global Key Manufacturers of Hirudin, Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 India Hirudin Market Size by Company
4.7.1 Key Players of Hirudin in India, Ranked by Revenue (2022)
4.7.2 India Hirudin Revenue by Players (2018-2023)
4.7.3 India Hirudin Sales by Players (2018-2023)
5 Global Hirudin Market Size by Region
5.1 Global Hirudin Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Hirudin Market Size in Volume by Region (2018-2029)
5.2.1 Global Hirudin Sales in Volume by Region: 2018-2023
5.2.2 Global Hirudin Sales in Volume Forecast by Region (2024-2029)
5.3 Global Hirudin Market Size in Value by Region (2018-2029)
5.3.1 Global Hirudin Sales in Value by Region: 2018-2023
5.3.2 Global Hirudin Sales in Value by Region: 2024-2029
6 Americas
6.1 Americas Hirudin Market Size YoY Growth 2018-2029
6.2 Americas Hirudin Sales in Volume, by Type (2018, 2022 & 2029)
6.3 Americas Hirudin Sales in Volume, by Application (2018, 2022 & 2029)
6.4 Americas Hirudin Market Facts & Figures by Country (2018, 2022 & 2029)
6.4.1 Americas Hirudin Sales in Value by Country (2018, 2022 & 2029)
6.4.2 Americas Hirudin Sales in Volume by Country (2018, 2022 & 2029)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA Hirudin Market Size YoY Growth 2018-2029
7.2 EMEA Hirudin Sales in Volume, by Type (2018, 2022 & 2029)
7.3 EMEA Hirudin Sales in Volume, by Application (2018, 2022 & 2029)
7.4 EMEA Hirudin Market Facts & Figures by Country (2018, 2022 & 2029)
7.4.1 EMEA Hirudin Sales in Value by Country (2018, 2022 & 2029)
7.4.2 EMEA Hirudin Sales in Volume by Country (2018, 2022 & 2029)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China Hirudin Market Size YoY Growth 2018-2029
8.2 China Hirudin Sales in Volume, by Type (2018, 2022 & 2029)
8.3 China Hirudin Sales in Volume, by Application (2018, 2022 & 2029)
9 APAC
9.1 APAC Hirudin Market Size YoY Growth 2018-2029
9.2 APAC Hirudin Sales in Volume, by Type (2018, 2022 & 2029)
9.3 APAC Hirudin Sales in Volume, by Application (2018, 2022 & 2029)
9.4 APAC Hirudin Market Facts & Figures by Region (2018, 2022 & 2029)
9.4.1 APAC Hirudin Sales in Value by Region (2018, 2022 & 2029)
9.4.2 APAC Hirudin Sales in Volume by Region (2018, 2022 & 2029)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 The Medicines Company
10.1.1 The Medicines Company Company Information
10.1.2 The Medicines Company Description and Business Overview
10.1.3 The Medicines Company Hirudin Sales, Revenue and Gross Margin (2018-2023)
10.1.4 The Medicines Company Hirudin Products Offered
10.1.5 The Medicines Company Recent Development
10.2 Keyken
10.2.1 Keyken Company Information
10.2.2 Keyken Description and Business Overview
10.2.3 Keyken Hirudin Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Keyken Hirudin Products Offered
10.2.5 Keyken Recent Development
10.3 Minapharm
10.3.1 Minapharm Company Information
10.3.2 Minapharm Description and Business Overview
10.3.3 Minapharm Hirudin Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Minapharm Hirudin Products Offered
10.3.5 Minapharm Recent Development
10.4 Abbott
10.4.1 Abbott Company Information
10.4.2 Abbott Description and Business Overview
10.4.3 Abbott Hirudin Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Abbott Hirudin Products Offered
10.4.5 Abbott Recent Development
10.5 SALUBRIS
10.5.1 SALUBRIS Company Information
10.5.2 SALUBRIS Description and Business Overview
10.5.3 SALUBRIS Hirudin Sales, Revenue and Gross Margin (2018-2023)
10.5.4 SALUBRIS Hirudin Products Offered
10.5.5 SALUBRIS Recent Development
10.6 Pfizer, Inc
10.6.1 Pfizer, Inc Company Information
10.6.2 Pfizer, Inc Description and Business Overview
10.6.3 Pfizer, Inc Hirudin Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Pfizer, Inc Hirudin Products Offered
10.6.5 Pfizer, Inc Recent Development
10.7 Teva Pharmaceutical Industries Ltd
10.7.1 Teva Pharmaceutical Industries Ltd Company Information
10.7.2 Teva Pharmaceutical Industries Ltd Description and Business Overview
10.7.3 Teva Pharmaceutical Industries Ltd Hirudin Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Teva Pharmaceutical Industries Ltd Hirudin Products Offered
10.7.5 Teva Pharmaceutical Industries Ltd Recent Development
10.8 DUOPUTAI
10.8.1 DUOPUTAI Company Information
10.8.2 DUOPUTAI Description and Business Overview
10.8.3 DUOPUTAI Hirudin Sales, Revenue and Gross Margin (2018-2023)
10.8.4 DUOPUTAI Hirudin Products Offered
10.8.5 DUOPUTAI Recent Development
10.9 Pentapharm
10.9.1 Pentapharm Company Information
10.9.2 Pentapharm Description and Business Overview
10.9.3 Pentapharm Hirudin Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Pentapharm Hirudin Products Offered
10.9.5 Pentapharm Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 Hirudin Industry Chain Analysis
11.2 Hirudin Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 Hirudin Production Mode & Process
11.4 Hirudin Sales and Marketing
11.4.1 Hirudin Sales Channels
11.4.2 Hirudin Distributors
11.5 Hirudin Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
    Table 1. Hirudin CAGR in Value, India VS Global, 2018 VS 2022 VS 2029
    Table 2. Hirudin Market Trends
    Table 3. Hirudin Market Drivers
    Table 4. Hirudin Market Challenges
    Table 5. Hirudin Market Restraints
    Table 6. Global Hirudin Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)
    Table 7. India Hirudin Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)
    Table 8. Global Hirudin Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 9. India Hirudin Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 10. Global Key Manufacturers of Hirudin, Ranked by Revenue (2022) & (US$ Million)
    Table 11. Global Hirudin Revenue by Manufacturer, (US$ Million), 2018-2023
    Table 12. Global Hirudin Revenue Share by Manufacturer, 2018-2023
    Table 13. Global Hirudin Sales by Manufacturer, (K MT), 2018-2023
    Table 14. Global Hirudin Sales Share by Manufacturer, 2018-2023
    Table 15. Global Hirudin Price by Manufacturer (2018-2023) & (USD/MT)
    Table 16. Global Hirudin Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Hirudin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hirudin as of 2022)
    Table 18. Global Key Manufacturers of Hirudin, Manufacturing Base Distribution and Headquarters
    Table 19. Global Key Manufacturers of Hirudin, Product Offered and Application
    Table 20. Global Key Manufacturers of Hirudin, Date of Enter into This Industry
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Key Players of Hirudin in India, Ranked by Revenue (2022) & (US$ million)
    Table 23. India Hirudin Revenue by Players, (US$ Million), (2018-2023)
    Table 24. India Hirudin Revenue Share by Players, (2018-2023)
    Table 25. India Hirudin Sales by Players, (K MT), (2018-2023)
    Table 26. India Hirudin Sales Share by Players, (2018-2023)
    Table 27. Global Hirudin Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 28. Global Hirudin Sales in Volume by Region (2018-2023) & (K MT)
    Table 29. Global Hirudin Sales in Volume Forecast by Region (2024-2029) & (K MT)
    Table 30. Global Hirudin Sales in Value by Region (2018-2023) & (US$ Million)
    Table 31. Global Hirudin Sales in Value Forecast by Region (2024-2029) & (US$ Million)
    Table 32. Americas Hirudin Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 33. Americas Hirudin Sales in Value by Country (2018-2023) & (US$ Million)
    Table 34. Americas Hirudin Sales in Value by Country (2024-2029) & (US$ Million)
    Table 35. Americas Hirudin Sales in Volume by Country (2018-2023) & (K MT)
    Table 36. Americas Hirudin Sales in Volume by Country (2024-2029) & (K MT)
    Table 37. EMEA Hirudin Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 38. EMEA Hirudin Sales in Value by Country (2018-2023) & (US$ Million)
    Table 39. EMEA Hirudin Sales in Value by Country (2024-2029) & (US$ Million)
    Table 40. EMEA Hirudin Sales in Volume by Country (2018-2023) & (K MT)
    Table 41. EMEA Hirudin Sales in Volume by Country (2024-2029) & (K MT)
    Table 42. APAC Hirudin Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 43. APAC Hirudin Sales in Value by Country (2018-2023) & (US$ Million)
    Table 44. APAC Hirudin Sales in Value by Country (2024-2029) & (US$ Million)
    Table 45. APAC Hirudin Sales in Volume by Country (2018-2023) & (K MT)
    Table 46. APAC Hirudin Sales in Volume by Country (2024-2029) & (K MT)
    Table 47. The Medicines Company Company Information
    Table 48. The Medicines Company Description and Business Overview
    Table 49. The Medicines Company Hirudin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
    Table 50. The Medicines Company Hirudin Product
    Table 51. The Medicines Company Recent Development
    Table 52. Keyken Company Information
    Table 53. Keyken Description and Business Overview
    Table 54. Keyken Hirudin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
    Table 55. Keyken Hirudin Product
    Table 56. Keyken Recent Development
    Table 57. Minapharm Company Information
    Table 58. Minapharm Description and Business Overview
    Table 59. Minapharm Hirudin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
    Table 60. Minapharm Hirudin Product
    Table 61. Minapharm Recent Development
    Table 62. Abbott Company Information
    Table 63. Abbott Description and Business Overview
    Table 64. Abbott Hirudin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
    Table 65. Abbott Hirudin Product
    Table 66. Abbott Recent Development
    Table 67. SALUBRIS Company Information
    Table 68. SALUBRIS Description and Business Overview
    Table 69. SALUBRIS Hirudin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
    Table 70. SALUBRIS Hirudin Product
    Table 71. SALUBRIS Recent Development
    Table 72. Pfizer, Inc Company Information
    Table 73. Pfizer, Inc Description and Business Overview
    Table 74. Pfizer, Inc Hirudin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
    Table 75. Pfizer, Inc Hirudin Product
    Table 76. Pfizer, Inc Recent Development
    Table 77. Teva Pharmaceutical Industries Ltd Company Information
    Table 78. Teva Pharmaceutical Industries Ltd Description and Business Overview
    Table 79. Teva Pharmaceutical Industries Ltd Hirudin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
    Table 80. Teva Pharmaceutical Industries Ltd Hirudin Product
    Table 81. Teva Pharmaceutical Industries Ltd Recent Development
    Table 82. DUOPUTAI Company Information
    Table 83. DUOPUTAI Description and Business Overview
    Table 84. DUOPUTAI Hirudin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
    Table 85. DUOPUTAI Hirudin Product
    Table 86. DUOPUTAI Recent Development
    Table 87. Pentapharm Company Information
    Table 88. Pentapharm Description and Business Overview
    Table 89. Pentapharm Hirudin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
    Table 90. Pentapharm Hirudin Product
    Table 91. Pentapharm Recent Development
    Table 92. Key Raw Materials Lists
    Table 93. Raw Materials Key Suppliers Lists
    Table 94. Hirudin Customers List
    Table 95. Hirudin Distributors List
    Table 96. Research Programs/Design for This Report
    Table 97. Key Data Information from Secondary Sources
    Table 98. Key Data Information from Primary Sources
List of Figures
    Figure 1. Hirudin Product Picture
    Figure 2. Global Hirudin Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 3. Global Hirudin Market Size 2018-2029 (US$ Million)
    Figure 4. Global Hirudin Sales 2018-2029 (K MT)
    Figure 5. India Hirudin Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 6. India Hirudin Market Size 2018-2029 (US$ Million)
    Figure 7. India Hirudin Sales 2018-2029 (K MT)
    Figure 8. India Hirudin Market Share in Global, in Value (US$ Million) 2018-2029
    Figure 9. India Hirudin Market Share in Global, in Volume (K MT) 2018-2029
    Figure 10. Hirudin Report Years Considered
    Figure 11. Product Picture of Natural Hirudin
    Figure 12. Product Picture of Recombinant Hirudin
    Figure 13. Global Hirudin Market Share by Type in 2022 & 2029
    Figure 14. Global Hirudin Sales in Value by Type (2018-2029) & (US$ Million)
    Figure 15. Global Hirudin Sales Market Share in Value by Type (2018-2029)
    Figure 16. Global Hirudin Sales by Type (2018-2029) & (K MT)
    Figure 17. Global Hirudin Sales Market Share in Volume by Type (2018-2029)
    Figure 18. Global Hirudin Price by Type (2018-2029) & (USD/MT)
    Figure 19. India Hirudin Market Share by Type in 2022 & 2029
    Figure 20. India Hirudin Sales in Value by Type (2018-2029) & (US$ Million)
    Figure 21. India Hirudin Sales Market Share in Value by Type (2018-2029)
    Figure 22. India Hirudin Sales by Type (2018-2029) & (K MT)
    Figure 23. India Hirudin Sales Market Share in Volume by Type (2018-2029)
    Figure 24. India Hirudin Price by Type (2018-2029) & (USD/MT)
    Figure 25. Product Picture of Thrombosis Disease
    Figure 26. Product Picture of Tumor Disease
    Figure 27. Product Picture of Others
    Figure 28. Global Hirudin Market Share by Application in 2022 & 2029
    Figure 29. Global Hirudin Sales in Value by Application (2018-2029) & (US$ Million)
    Figure 30. Global Hirudin Sales Market Share in Value by Application (2018-2029)
    Figure 31. Global Hirudin Sales by Application (2018-2029) & (K MT)
    Figure 32. Global Hirudin Sales Market Share in Volume by Application (2018-2029)
    Figure 33. Global Hirudin Price by Application (2018-2029) & (USD/MT)
    Figure 34. India Hirudin Market Share by Application in 2022 & 2029
    Figure 35. India Hirudin Sales in Value by Application (2018-2029) & (US$ Million)
    Figure 36. India Hirudin Sales Market Share in Value by Application (2018-2029)
    Figure 37. India Hirudin Sales by Application (2018-2029) & (K MT)
    Figure 38. India Hirudin Sales Market Share in Volume by Application (2018-2029)
    Figure 39. India Hirudin Price by Application (2018-2029) & (USD/MT)
    Figure 40. Americas Hirudin Sales in Volume Growth Rate 2018-2029 (K MT)
    Figure 41. Americas Hirudin Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 42. Americas Hirudin Sales by Type (2018-2029) & (K MT)
    Figure 43. Americas Hirudin Sales Market Share in Volume by Type (2018-2029)
    Figure 44. Americas Hirudin Sales by Application (2018-2029) & (K MT)
    Figure 45. Americas Hirudin Sales Market Share in Volume by Application (2018-2029)
    Figure 46. United States Hirudin Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 47. Canada Hirudin Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 48. Mexico Hirudin Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 49. Brazil Hirudin Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 50. EMEA Hirudin Sales in Volume Growth Rate 2018-2029 (K MT)
    Figure 51. EMEA Hirudin Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 52. EMEA Hirudin Sales by Type (2018-2029) & (K MT)
    Figure 53. EMEA Hirudin Sales Market Share in Volume by Type (2018-2029)
    Figure 54. EMEA Hirudin Sales by Application (2018-2029) & (K MT)
    Figure 55. EMEA Hirudin Sales Market Share in Volume by Application (2018-2029)
    Figure 56. Europe Hirudin Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 57. Middle East Hirudin Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 58. Africa Hirudin Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 59. China Hirudin Sales in Volume Growth Rate 2018-2029 (K MT)
    Figure 60. China Hirudin Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 61. China Hirudin Sales by Type (2018-2029) & (K MT)
    Figure 62. China Hirudin Sales Market Share in Volume by Type (2018-2029)
    Figure 63. China Hirudin Sales by Application (2018-2029) & (K MT)
    Figure 64. China Hirudin Sales Market Share in Volume by Application (2018-2029)
    Figure 65. APAC Hirudin Sales in Volume Growth Rate 2018-2029 (K MT)
    Figure 66. APAC Hirudin Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 67. APAC Hirudin Sales by Type (2018-2029) & (K MT)
    Figure 68. APAC Hirudin Sales Market Share in Volume by Type (2018-2029)
    Figure 69. APAC Hirudin Sales by Application (2018-2029) & (K MT)
    Figure 70. APAC Hirudin Sales Market Share in Volume by Application (2018-2029)
    Figure 71. Japan Hirudin Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 72. South Korea Hirudin Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 73. China Taiwan Hirudin Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 74. Southeast Asia Hirudin Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 75. India Hirudin Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 76. Hirudin Value Chain
    Figure 77. Hirudin Production Process
    Figure 78. Channels of Distribution
    Figure 79. Distributors Profiles
    Figure 80. Bottom-up and Top-down Approaches for This Report
    Figure 81. Data Triangulation
    Figure 82. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4350

This license allows only one user to access the PDF.
Electronic (PDF)

$6525

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$8700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Coronary Imaging Catheter Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32P14840
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Digital Platform for Chronic Kidney Disease (CKD) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-20V18395
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Continuous Glucose Monitoring Sensor Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32G20014
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Radioactive Iodine Ablation Therapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9U20281
Tue Dec 02 00:00:00 UTC 2025

Add to Cart